-
公开(公告)号:EP4317439A1
公开(公告)日:2024-02-07
申请号:EP22781256.7
申请日:2022-03-31
发明人: YOSHIDA, Tetsuya , YOSHIKAWA, Mai , HARUNA, Miya , NAGIRA, Morio , TAKAHASHI, Koji , HAYASHIDA, Marina , MIWA, Hiroto , SONODA, Yudai , OHKURA, Naganari , SAKAGUCHI, Shimon , WADA, Hisashi
IPC分类号: C12N15/62 , A61K35/17 , A61P35/00 , C07K14/725 , C07K16/28 , C07K19/00 , C12N5/10 , C12N15/12 , C12N15/13 , C12N15/63
摘要: The chimeric antigen receptor that recognizes CCR8 as an antigen of the present invention has cytotoxic activity against CCR8-expressing cells by being expressed in effector cells.
-
公开(公告)号:EP4428239A1
公开(公告)日:2024-09-11
申请号:EP22887213.1
申请日:2022-10-31
申请人: Shionogi & Co., Ltd
IPC分类号: C12N15/13 , A61K39/395 , A61P17/04 , A61P25/04 , A61P29/00 , A61P29/02 , C07K16/18 , C07K16/28 , C12N15/63
CPC分类号: A61K39/395 , A61P17/04 , A61P25/04 , A61P29/00 , A61P29/02 , C07K16/00 , C07K16/18 , C07K16/28 , C12N15/63
摘要: Objective of the present invention is to provide a novel Nav1.7 monoclonal antibody. It discloses a Nav1.7 monoclonal antibody or its antibody fragment, having specific six CDRs or specific heavy chain variable regions/light chain variable regions. The monoclonal antibody and the like can be used for treating or preventing pain, pruritus and so on.
-